Thus, our results indicate that the immunohistochemical expression of SSTR2A protein could serve as a prognostic biomarker among anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted. The gene discussed is IDH2; the disease is anaplastic oligodendroglioma.